Profile: Protein Sciences Corporation is a vaccine company, which develops vaccines and biopharmaceuticals. Our product area includes expresSF+® insect cells, HIV & SIV research proteins, influenza research proteins and influenza antibodies. Our expresSF+® cells manufactured from the fall army worm Spodoptera frugiperda optimizes the production of recombinant proteins. Our cells are serum-free, have high-density growth and gene expression capability. They do not clump or aggregate and have a doubling time of 18-24 hours. Our HIV-1 gp120 is produced from insect cells. It is produced using recombinant baculovirus vectors which are secreted from insect cells in serum-free media and are purified under non-denaturing conditions.

The company has revenues of USD 5-10 Million, has ~20 employees.